69 Best Genetics Startups to Watch in 2024

Oral antifungal therapy developer to treat life-threatening rare fungal infections

Total Raised: $170.00M

Last Funding: $100.00M (Series D)

Developer of immunoglobulin E (IgE) antibodies to treat cancer.

Total Raised: $64.47M

Last Funding: $16.50M (Series B)

Programming biolCellibre is a best-in-class manufacturing technology company.. Employing an organism-agnostic approach, we turn cells into specialized, sustainable factories for the manufacture of globally significant products at scale.ogy to turn cells into factories company

Total Raised: $18.21M

Last Funding: $6.71M (Unknown)

Human genome sequencing company founded in 2013 and based in San Diego, CA. Human Longevity Inc. is building a database with genomic and phenotypic information and aims to make medicine more data-driven by combining DNA sequencing, expert analysis and machine learning

Total Raised: $39.80M

Last Funding: $39.80M (Series B)

MiLaboratories is a bioinformatics solutions to probe adaptive immunity founded in 2021 by Stanislav Poslavsky.

Total Raised: $12.30M

Last Funding: $10.00M (Series A)

Platform for analyzing single molecules like DNA, RNA, and proteins using nanopore-based electronic systems.

Total Raised: $275.13M

Last Funding: $275.13M (Unknown)

Platform focused on decoding the dark matter of the human genome to discover new treatments for diseases.

Total Raised: $43.51M

Last Funding: $43.51M (Unknown)

Platform dedicated to helping patients with autoimmune rheumatic diseases through scientific discovery.

Total Raised: $42.03M

Last Funding: $42.03M (Unknown)

SOPHiA GENETICS is a healthcare technology company and developer of SOPHiA Artificial Intelligence for clinical genomics.

Total Raised: $110.00M

Last Funding: $110.00M (Unknown)

CENTOGENE is a Rostock-based healthcare company developing methods and technologies for genetics analysis.

Total Raised: $28.00M

Last Funding: $28.00M (Series A)

Platform for gene and cell therapy companies to develop cheaper drugs faster using digital tools.

Total Raised: $10.50M

Last Funding: $10.00M (Seed)

Biotechnology company focused on developing therapeutic medicines by harnessing gene activation mechanisms.

Total Raised: $29.91M

Last Funding: $29.91M (Unknown)

Genetic analysis technology for decoding the dynamic genome.

Total Raised: $35.40M

Last Funding: $35.40M (Series A)

A biotechnology company developing intracellular genetic protein therapy to treat chronic heart failure

Total Raised: $6.30M

Last Funding: $6.30M (Series B)

DNA sequencing system focused on advancing 3-D sequencing for life science improvements.

Total Raised: $7.47M

Last Funding: $1.56M (Seed)

Digital health platform offering advanced genetic tests for personalized disease prevention.

Total Raised: $2.20M

Last Funding: $1.63M (Seed)

Biotechnology company developing resilient and sustainable crops.

Total Raised: $5.70M

Last Funding: $5.70M (Seed)

A software solutions company providing bioinformatics solutions to life science and other sector

Total Raised: $12.64M

Last Funding: $3.64M (Seed)

Biotechnology company based in Paris, focusing on innovative genetic analysis solutions.

Total Raised: $12.89M

Last Funding: $12.89M (Unknown)

Healthcare firm offering clinical genetic testing to patients.

Total Raised: $16.54M

Last Funding: $16.54M (Unknown)

Diagnostic tool that turns the latest research into products for better health and well-being.

Total Raised: $6.23M

Last Funding: $6.23M (Unknown)

Gene editing therapeutics.

Total Raised: $12.58M

Last Funding: $12.58M (Seed)

Liquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency.

Total Raised: $4.23M

Last Funding: $4.23M (Series A)

Consumable reagent kits enabling analysis of gene editing efficiency and specificity.

Total Raised: $1.14M

Last Funding: $1.14M (Unknown)

Genomics software facilitating the transition of Polygenic Risk Scores from research to clinical use.

Total Raised: $1.75M

Last Funding: $1.75M (Unknown)

A digital fertility clinic for men providing personalized care and services.

Total Raised: $2.13M

Last Funding: $2.13M (Seed)

A software solutions company providing bioinformatics solutions to life science and other sector

Total Raised: $2.26M

Last Funding: $0.74M (Unknown)

Platform for analyzing genetic data to drive innovation in precision medicine.

Total Raised: $2.25M

Last Funding: $2.25M (Seed)

AI-powered genetic analysis for rare deseases.

Total Raised: $1.23M

Last Funding: $1.23M (Seed)

MOG is your personal genomics company.

Total Raised: $2.78M

Last Funding: $2.78M (Unknown)

Genetic platform helping patients achieve health, nutrition, and fitness goals.

Total Raised: $0.42M

Last Funding: $0.42M (Pre Seed)

AveXis, Inc is now called Novartis Gene Therapies, it is a company that is committed to developing and commercializing gene therapies.

Hui-Gene Therapeutics is a company founded in 2018 by Xuan Yao.

Engine Biosciences is a San Francisco-based AI company that is focused on drugs development.

Locanabio is a San Diego, California-based biotechnology company developing RNA-targeting gene therapies.

23andMe is a biotechnology company based in Mountain View, California providing DNA genetic testing and analysis services.

Bioinformatics software enabling fast visualization and an intuitive user interface.

Last Funding: $0.00M (Unknown)

Platform focused on preventing and managing type 2 diabetes.

Last Funding: $0.00M (Unknown)

Diagnostic decision support platform for biotechnology applications.

Last Funding: $0.00M (Unknown)

A biotechnology company using genetic editing technologies to develop therapies for the treatment of cancer and genetic diseases.

MedGenome is a Foster City, California-based company developing DNA generation sequencing and data analysis technology founded in 2013 by Mahesh Pratapneni.

Datar Cancer Genetics is a Nashik-based company developing non-invasive cancer diagnostics founded in 1992.

AnchorDx is a high-throughput sequencing platform founded in 1996 by Fan Jianbing.

A genetic medicines company in Massachusetts that focuses on patients suffering from rare genetic diseases.

BridgeBio is a San Francisco-based biotechnology researching and producing genetically-targeted therapeutics.

Akouos is a Brookline, Massachusetts-based biotechnology company developing precision genetics-based medicines founded in 2016 by Emmanuel Simons.